Literature DB >> 29192324

A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.

Kayo Fujikake1, Hiroaki Kajiyama1, Masato Yoshihara1, Kimihiro Nishino1, Nobuhisa Yoshikawa1, Fumi Utsumi1, Shiro Suzuki1, Kaoru Niimi1, Jun Sakata1, Hiroko Mitsui2, Kiyosumi Shibata3, Takeshi Senga4, Fumitaka Kikkawa1.   

Abstract

Epithelial ovarian cancer (EOC) is believed to cause peritoneum dissemination through microenvironmental cell‑to-cell communication between the tumor and mesothelium, leading to the further acquisition of progressive and metastatic potentials. In the present study, we aimed to determine the role of cancer-associated mesothelial cells (CAMCs) in the promotion of tumor neovascularization and vascular permeability via enhanced vascular endothelial growth factor (VEGF) production. We examined whether a characteristic morphological change in human peritoneal mesothelial cells (HPMCs) was observed in the presence of malignant ascites and tumor-derived TGF-β. We focused on the enhanced production of VEGF in CAMCs and its crucial role in endothelial migration and tube formation. Normal HPMCs showed an epithelial morphology with a cobblestone appearance. When HPMCs were co-cultured with malignant ascites from patients with advanced EOC, a dramatic morphologic change was noted from an epithelioid pattern to an α-SMA-positive fibroblastic, mesenchymal pattern. Additionally, we found that EOC-derived TGF-β induced typical EMT-like morphological alteration in HPMCs, which was associated with CAMCs. We further discovered that CAMCs play a crucial role in the enhanced migration and tube formation of endothelial cells by the promotion of VEGF production. In conclusion, our findings indicate the possible involvement of CAMCs in the neovascularization of EOC and enhancement of vascular permeability, resulting in the formation of malignant ascites. The novel mechanism of CAMCs as a facilitator of EOC progression is displayed by microenvironmental cell-to-cell communication between EOC and the mesothelium.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29192324     DOI: 10.3892/or.2017.6104

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk.

Authors:  Peter C Hart; Hilary A Kenny; Niklas Grassl; Karen M Watters; Lacey M Litchfield; Fabian Coscia; Ivana Blaženović; Lisa Ploetzky; Oliver Fiehn; Matthias Mann; Ernst Lengyel; Iris L Romero
Journal:  Cell Rep       Date:  2019-12-17       Impact factor: 9.423

Review 2.  Friend and foe: the regulation network of ascites components in ovarian cancer progression.

Authors:  Zhe Geng; Xinxing Pan; Juan Xu; Xuemei Jia
Journal:  J Cell Commun Signal       Date:  2022-10-13       Impact factor: 5.908

Review 3.  The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.

Authors:  Sabrina J Ritch; Carlos M Telleria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

4.  CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.

Authors:  Hiroaki Yasui; Hiroaki Kajiyama; Satoshi Tamauchi; Shiro Suzuki; Yang Peng; Nobuhisa Yoshikawa; Mai Sugiyama; Kae Nakamura; Fumitaka Kikkawa
Journal:  Clin Exp Metastasis       Date:  2019-09-21       Impact factor: 5.150

5.  Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.

Authors:  Kazuhisa Kitami; Masato Yoshihara; Yoshihiro Koya; Mai Sugiyama; Shohei Iyoshi; Kaname Uno; Kazumasa Mogi; Sho Tano; Hiroki Fujimoto; Akihiro Nawa; Fumitaka Kikkawa; Hiroaki Kajiyama
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

6.  Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis.

Authors:  Danila Del Rio; Ilenia Masi; Valentina Caprara; Francesca Spadaro; Flavia Ottavi; Raffaele Strippoli; Pilar Sandoval; Manuel López-Cabrera; Ricardo Sainz de la Cuesta; Anna Bagnato; Laura Rosanò
Journal:  Front Cell Dev Biol       Date:  2021-12-01

Review 7.  The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer.

Authors:  Aiping Zheng; Yuhao Wei; Yunuo Zhao; Tao Zhang; Xuelei Ma
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

Review 8.  Regulation of Mesothelial Cell Fate during Development and Human Diseases.

Authors:  Toshiaki Taniguchi; Hiroyuki Tomita; Tomohiro Kanayama; Kazumasa Mogi; Yoshihiro Koya; Yoshihiko Yamakita; Masato Yoshihara; Hiroaki Kajiyama; Akira Hara
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

9.  Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.

Authors:  Masato Yoshihara; Hiroaki Kajiyama; Akira Yokoi; Mai Sugiyama; Yoshihiro Koya; Yoshihiko Yamakita; Wenting Liu; Kae Nakamura; Yoshinori Moriyama; Hiroaki Yasui; Shiro Suzuki; Yusuke Yamamoto; Carmela Ricciardelli; Akihiro Nawa; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Int J Cancer       Date:  2020-01-24       Impact factor: 7.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.